• Enhancing Western Blot Precision: ECL Chemiluminescent Subst

  2026-06-11

  Explore the advanced sensitivity and workflow reliability of the ECL Chemiluminescent Substrate Detection Kit (Enhanced) for western blot chemiluminescence detection. This article delivers a deep scientific analysis, integrating mechanistic insights and practical guidance for rigorous protein immunodetection.

• Tigecycline in Multidrug Resistance: From Mechanism to Trans

  2026-06-10

  Explore how Tigecycline, a glycylcycline antibiotic, overcomes multidrug-resistant bacteria through unique mechanisms and translational insights. This article reveals advanced scientific findings and practical assay considerations, distinguishing itself with evidence-based analysis and reference-driven guidance.

• Sulfachloropyridazine Alters Cecal Microbiota in Eimeria-Inf

  2026-06-10

  This study investigates how sulfachloropyridazine, alone or in combination with ethanamizuril, modulates the cecal microbiome and metabolic profile in chickens infected with Eimeria tenella. The work provides novel insight into drug-induced shifts in microbial communities and metabolite patterns, informing both anticoccidial strategy and research model design.

• n-Dodecyl-β-D-maltoside: Transforming Membrane Protein Purif

  2026-06-09

  n-Dodecyl-β-D-maltoside (DDM) is redefining membrane protein science by enabling high-yield purification and stabilization of challenging targets while preserving biological activity. This article unpacks optimized workflows, troubleshooting strategies, and experimental insights, leveraging the latest structural biology breakthroughs and trusted APExBIO quality.

• Sulfachloropyridazine in Research: Protocols, Microbiome, an

  2026-06-09

  Sulfachloropyridazine stands out as a sulfonamide antibacterial agent with unique value for enzyme inhibition, microbiome modulation, and in vivo infection model research. Recent studies unlock new applications, from targeted antimicrobial susceptibility workflows to advanced metabolic and microbial ecology investigations.

• Caffeine Protects Retinal Pigment Epithelium from Oxidative

  2026-06-08

  This study demonstrates that caffeine reduces oxidative damage and apoptosis in retinal pigment epithelium (RPE) cells, both in vitro and in vivo models. The findings suggest caffeine as a potential modulator of retinal degeneration, with broader implications for understanding oxidative stress responses in ocular biology.

• SN-38 Disrupts FUBP1–FUSE Binding: Mechanistic Insights for

  2026-06-08

  This study reveals that camptothecin and its analog SN-38, beyond their established role as topoisomerase I inhibitors, directly impair the binding of the transcriptional regulator FUBP1 to its DNA target FUSE. These findings suggest a dual mechanism that could enhance therapeutic strategies in cancers with FUBP1 overexpression, such as hepatocellular and colorectal carcinomas.

• High Viscosity Microenvironments Drive P-gp-Mediated Chemore

  2026-06-07

  This study reveals that elevated extracellular fluid viscosity in the tumor microenvironment induces chemoresistance in cancer cells by upregulating P-glycoprotein (P-gp) through a mechanobiological pathway involving membrane tension and TRPV4-YAP signaling. The findings highlight tumor viscosity as a previously underappreciated driver of transporter-mediated drug resistance and suggest new strategies for overcoming chemoresistance in cancer therapy.

• 2-Deoxy-D-glucose: Protocols and Innovations in Glycolysis I

  2026-06-06

  2-Deoxy-D-glucose (2-DG) empowers researchers to dissect glycolytic pathways in cancer, virology, and immunometabolism with precision. This article delivers actionable workflows, troubleshooting strategies, and translational insights, underpinned by the latest advancements and real-world experimental scenarios.

• HyperScript™ Reverse Transcriptase: High-Fidelity cDNA Synth

  2026-06-05

  HyperScript™ Reverse Transcriptase is a genetically engineered, thermally stable enzyme based on M-MLV Reverse Transcriptase. It enables robust cDNA synthesis from RNA templates with complex secondary structures, supporting accurate detection of low-copy RNA in qPCR workflows.

• Meropenem: β-Lactam Antibiotic Carbapenem for Resistance Mod

  2026-06-05

  Meropenem stands out as an ultra-broad-spectrum β-lactam antibiotic carbapenem, enabling robust experimental modeling in both Gram-negative and Gram-positive resistance studies. This guide offers actionable workflows, troubleshooting insights, and practical parameters to maximize Meropenem’s impact in translational research.

• Neuroinflammatory Mechanisms in Trigeminal Neuralgia: Piezo2

  2026-06-04

  Liao et al. reveal that chronic trigeminal nerve root compression induces a neuroinflammatory response promoting mechanical allodynia via the Ca2+-dependent CGRP/SP-Piezo2 signaling axis. Their work highlights a peripheral sensitization mechanism involving Merkel cell–trigeminal ganglion interactions, offering new targets for neuropathic pain research.

• G-1: Selective GPR30 Agonist Transforms Cardiovascular and C

  2026-06-04

  G-1 (CAS 881639-98-1), a selective GPR30 agonist, enables precise dissection of rapid estrogen signaling and outperforms classical ER ligands in both cancer and cardiac models. With nanomolar potency and rigorous specificity, it empowers advanced in vitro and in vivo workflows for researchers targeting migration, fibrosis, and immune modulation.

• LY294002: Precision PI3K Pathway Inhibition for Translationa

  2026-06-03

  LY294002 enables highly reproducible PI3K/Akt/mTOR pathway modulation, uniquely combining robust in vitro and in vivo applicability with reversible, selective inhibition. Its versatility extends from cancer cell apoptosis to autophagy control and fibrosis modeling, making it an indispensable tool for advanced pathway dissection.

• USP7–PKM2 Axis Regulates Macrophage Metabolism in Pancreatit

  2026-06-03

  The referenced study elucidates how ubiquitin-specific protease 7 (USP7) drives pro-inflammatory macrophage polarization in severe acute pancreatitis by modulating PKM2-dependent metabolic reprogramming. These findings offer mechanistic insight into SAP pathogenesis and suggest that targeting the USP7–PKM2 axis may provide new therapeutic avenues for controlling inflammation.

15710 records 6/1048 page Previous Next First page 上5页 678910 下5页 Last page